Alfie Health Raises $2.1M for AI-powered Weight Loss Platform
Alfie Health's $2.1 million seed funding was led by Y Combinator and Nina Capital. It included participation from Goodwater Capital, Phoenix Investment Club and several angel investors.
LifeMD Launches GLP-1 Weight Management Program
Through LifeMD's new weight management program, consumers can gain access to GLP-1 prescriptions like Ozempic and Wegovy, clinical support, lab testing, education and more.
presented by
The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Found Launches Employer-focused Obesity Care Program
Found for Business is an evidence-based obesity care program that prescribes 13 different medications (including GLP-1s) in 60 different combinations. It combines the medication with support from providers, coaching and an app that offers meal and activity tracking.
WeightWatchers To Acquire Chronic Weight Management Digital Health Platform
WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription medications, including Ozempic and Wegovy. The deal is anticipated to close during the second quarter of 2023, and WeightWatchers will pay the net purchase price of $106 million.
Obesity is a disease—and it’s treatable
Obesity is a disease, and America’s healthcare providers and hospital systems must be part of changing how we treat it. That means many of us in the health ecosystem must reexamine how we view patients with excess weight.
Livongo’s latest acquisition adds personalized weight management, diabetes prevention business
The deal will give Livongo the ability to provide a wider spectrum of services for employer wellness and health plan members.
presented by
The Top Surgical Instruments Needed for Extractions
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
BAROnova brings in $36.5M Series D for implanted weight-loss device
BAROnova has brought in significant capital to fund its U.S. clinical study of its endoscopically delivered weight-loss device, the TransPyloric Shuttle (TPS).